Medical Technology

@venturebeat.com 7 years ago

Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018

@venturebeat.com 7 years ago

Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR

@venturebeat.com 7 years ago

NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK

@venturebeat.com 7 years ago

Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel

@venturebeat.com 7 years ago

Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel

@venturebeat.com 7 years ago

Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand

@venturebeat.com 7 years ago

Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada

@venturebeat.com 7 years ago

Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer

@venturebeat.com 8 years ago

Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material